Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Half Yearly Report

4th Mar 2009 07:00

RNS Number : 2693O
PureCircle Limited
04 March 2009
 



PURECIRCLE LIMITED

("PureCircle" or "the Company")

Half yearly report for the six months ended 31 December 2008

PureCircle (www.purecircle.com), the world's leading producer of Natural High Intensity Sweeteners, including Reb A ('NHIS'), today announces results for the six months ended 31 December 2008. 

IN JUST SIX MONTHS

Global brand launches using PureCircle's Reb A confirm $10 billion market taking off

Regulatory approvals around the world

AustraliaNew ZealandSwitzerlandUS FDAEurope expected to follow

Global brands launched with Reb A

PepsiCo (Sobe LifeWater, Tropicana Juice)

The Coca-Cola Company (Sprite Green, Vitaminwater, Odwalla)

Whole Earth (PureVia table-top)

Cargill (Truvia table-top)

Unprecedented rate of new product launches in just months since regulatory clearances 

Strong consumer pull-through indicates growing market demand

PureCircle is the clear industry leader in this fast-growth market

Q2: 9th record production quarter in last 12 quarters 

Q2 production exceeded annual rate of 300MT (Q2 FY 2008 90MT)

On track for Q4 annual rate of 700MT (Q4 FY 2008 200MT)

Multi-year, multi-$m contracts secured with Pepsico, Whole Earth, Cargill

Exclusive PureVia brand marketing & supply contracts signed

Strategic partnership agreed with Firmenich

Scaling-up the business to meet demand and maintain market leading position now key priority 

Expectation that customers will launch a succession of products using NHIS

Focus will be on ensuring that PureCircle remains the market's supplier partner of choice

Scaling business in line with industry demand

2,000 MT refinery by end 2009

4,000 MT extraction plant on stream April 2009

Leaf supply secured

Worldwide footprint in place to support global customers  

SUMMARY FINANCIALS

Six months ended 31 December  (US$m)

2008

(H1 FY 2009)

2007

(H1 FY 2008)

% growth FY 2009

vs FY 2008

Revenue

21.6

14.5*

49%

Gross Profit

8.6

4.5

91%

Net Profit after tax and minority

2.0

1.2

75%

*Included $5m of crude stevia sales now discontinued: like for like sales growth is 127%

Achieved Budget and strong growth against FY 2008 across all key performance measures

  

Paul Selway-Swift, Chairman of PureCircle, commented:

"We are pleased to report a strong first half performance. The Company achieved its budget targets and recorded significant growth in all key targets compared to a year ago.

Events are moving on at a pace in the wider market. With widespread regulatory clearances and many major product launches, it is clear that this is going to be a large global industry.

PureCircle is the undisputed market leader. We are demonstrably scaling our business rapidly and we have robust plans in place to keep doing so.

This is an exciting time for PureCircle. As with all businesses, challenges remain but we look forward to reporting on further progress."

4 March 2009

Enquiries

PureCircle Limited

Magomet Malsagov, Managing Director

+60 1 2388 8049

William Mitchell, Finance Director 

+44 7974 005 163

CollegeHill

+44 20 7457 2020

Mark Garraway

Adam Aljewicz

RFC Corporate Finance Ltd

+61 8 9480 2500

Stephen Allen

  Chairman's & Chief Executive's Statement

Overview

We are pleased to present the first half year results for financial year ending 30 June 2009 (FY2009) covering the period from 1 July 2008 to 31 December 2008.

This is an exciting new industry with significant growth potential. Moreover, PureCircle is the clear leader in developing the industry. At the time of our IPO in December 2007, we identified a number of hurdles that needed to be overcome if the industry were to take off. These were:

regulatory clearances 

product launches by major F&B producers

consumer pull-through

the ability to successfully scale-up the business

During the period, regulatory clearances were received in substantially all key markets culminating in the FDA's approval of Reb A in December, and we immediately saw a rapid launch of major global brands by F&B companies. With consumer pull-through on the back of these launcheswe expect to see the rate of new product launches gathering momentum.

With the market firmly established, our priority now is to ensure that we successfully scale-up the business to meet the expected demand and to ensure that we maintain our industry leading position.

Results

The first half FY 2009 saw a strong performance. The Group achieved its budget targets and recorded significant growth compared to FY 2008 across all our key performance indicators. 

Revenues were up by 49% to US$21.6 million (H1 FY2008: $14.5 million) reflecting increasing demand for our natural sweeteners. FY2008 sales included US$5 million of crude stevia extract sales in China now discontinued, therefore underlying sales growth was over 127%. Reb-A volumes were up over 125% at 95 MT (H1 FY2008: 42 MT). This compares to 115 MT sold in the whole of FY2008. 

With four months of the FY to run, the Group has 250 MT contracted being just over two thirds of the projected FY 2009 total. The Group is focused on securing the remaining 100MT.

The Group's long-term sales strategy is to secure a widely diversified customer base. Since 1 July 2008, the Group has started trading a number of multi-year non-exclusive contracts with major F&B companies including PepsiCo, Whole Earth and Cargill.

Gross margins improved 9 percentage points from 31% to 40% but, with projected volumes for FY2009 running at just 17.5% of December 2009 refinery capacity, the Group has significant potential to improve margins further as refining throughput increases and the Group reaps the benefits of economies of scale. 

The Group has a robust balance sheet with net assets of US$86.0 million and a strong cash position of US$27.3 million.

While the Company is growing its business, the Board deems working capital to be a priority. The Company will not be paying an interim dividend. This will be reviewed in the future in light of the Group's progress and funding requirements.

 

Business Review 

The period saw a number of exciting market and business developments. In summary there is undeniably now a global market for NHIS and PureCircle is the undisputed market leader.

Regulatory Approval and Product Launches

In December 2008 the US Food & Drug Administration ('FDA') gave Generally Recognised As Safe ('GRAS') clearance for high purity (97%) Reb-A.

Within days of the FDA's approval, early adopter F&B producers were unveiling plans for major brand launches into the US market. Product launches have so far included SoBe LifeWater and Tropicana Juice drinks by PepsiCo, Sprite Green, Odwalla and Vitaminwater by The Coca-Cola Company as well as PureVia and Truvia table-top products by Whole Earth and Cargill respectively.

Multi-million dollar advertising and promotional programmes have been launched to support these brands, including Sobe Lifewater's advertising during coverage of this year's NFL Super Bowl XLIII.  We expect more brands to be launched utilising our NHIS products over the next twelve months.

Customer Development

The global F&B market recognises that NHIS solutions will become the ideal complement to sugar in mainstream F&B production and that they will allow for the systematic reduction of calorific content across a range of categories and segments. This recognition provides for a major expansion of PureCircle's target customer base across a diverse F&B industry.

An integral part of the Group's marketing strategy is the provision of high value added products. To that end, the Group recently announced a strategic partnership with Firmenich, the world's largest privately-owned fragrance and flavouring company, to accelerate the commercialisation of the Group's NHIS solutions. The focus of the partnership will be the interaction between sweetener development and specific F&B category needs. 

Supply Chain

The Group is already the world's largest producer of NHIS. We continue to make progress on scaling our supply chain further.

The Group has secured sufficient leaf to deliver projected FY2009 volumes. Progress continues in diversifying leaf sources, particularly in Kenya and Paraguay where both quality and yields are highly encouraging. The Group is also investigating plantation-scale growing opportunities across a number of regions including South East AsiaSouth America and Africa.

The Group's expanded 4,000 MT extraction plant in China will be operational, as scheduled, in April 2009. The Group's capacity of 4,000 MT compares with an estimated rest of industry total of just over 3,500 MT and which is highly fragmented. 

The extension of the Group's refinery in Malaysia, to 2,000 MT is on schedule for completion by the end of 2009.

Management and Organisation

The Group has made a number of senior appointments in the last six months. It is notable that all of the appointees have joined from major companies in the F&B industry including a number from world-leading ingredients businesses.

The Group also established a sales presence in a number of countries including the United StatesParaguayAustraliaJapan and Switzerland.

Outlook

Developments over just the last few months have further strengthened our view that PureCircle has an exciting future as a mainstream food and beverage ingredients producer.

Recognition of NHIS as the long-awaited solution to a huge and growing global epidemic, places PureCircle in a strong position to leverage its first mover advantage based on an established supply chain, leading technology, strong market position, strategic partnerships and robust balance sheet. The prize is a slice of a rapidly growing $10 billion marketplace.

This is an exciting time for PureCircle. As with all businesses, challenges remain but we look forward to reporting on further progress.

Paul Selway-Swift, Chairman

Magomet Malsagov, Chief Executive

4 March 2009

  Half Year Financial Results 

For Financial Year Ending 30 June 2009

Unaudited

Pro-forma*

For 6 month

For 6 month

period to 

period to 

 31 Dec 2008

 31 Dec 2007

USD '000

USD '000

Continuing Operations

Revenue

21,564 

14,458 

**

Cost of sales

(12,915)

(9,912)

Gross profit

 

8,649 

 

4,546 

Other income

1,316 

Administrative expenses

(6,527)

(3,272)

 

 

 

 

 

Operating profit before finance expenses

2,122 

2,590 

Finance costs (net of foreign exchange)

(82)

(1,410)

 

 

 

 

 

Profit before taxation

2,040 

1,180 

Profit before taxation

 

2,040 

 

1,180 

Income tax expense

(13)

789 

Profit after taxation

 

2,027

 

1,969 

Attributable to:

Equity holders of the Company

2,063 

1,220 

Minority interests

 

(36)

 

749 

Earnings per share (US cents)

Basic

1.57 

0.94 

Diluted

 

1.55 

 

0.94 

*PureCircle Limited was incorporated on 23 July 2007 and acquired PureCircle Sdn Bhd ("PCSB") Group on 27 September 2007. Accordingly the Pro-forma for the period ended 31 December 2007 consolidated income statement covers the results for PureCicle Limited Group from 1 October 2007 to 31 December 2007 aggregated with the results for the PCSB Group from 1 July 2007 to 30 September 2007

**Includes $5m of sales of crude stevia extract now discontinued.   Condensed Consolidated Balance Sheets

As at 31 December 2008

Restated¹

Restated¹

Unaudited

Audited

Audited

31 Dec 2008

30 Jun 2008

31 Dec 2007

USD '000

USD '000

USD '000

Assets

Non-Current Assets

Property, plant and equipment

48,837 

31,912 

25,825 

Prepaid land lease payments

2,311 

2,285 

1,457 

Investment in associate

101 

126 

145 

Intangible assets

11,401 

7,987 

7,654 

 

62,650 

 

42,310 

 

35,081 

Current Assets

Inventories

36,081 

9,582 

12,499 

Trade receivables

14,997 

7,430 

3,406 

Other receivables

10,599 

7,642 

8,343 

Amount Due from Related Party

-

 1,433 

2,137 

Fixed deposits

14,927 

13,563 

31,543 

Cash and bank balances

12,418 

30,888 

12,721 

 

89,022 

 

70,538 

 

70,649 

Total Assets

151,672 

 

112,848 

 

105,730 

Equity and Liabilities

Equity attributable to equity holders of the Company

Share capital

13,272 

13,272 

13,029 

Share premium

64,224 

64,104 

55,697 

Treasury shares

 * 

 * 

 * 

Foreign currency translation reserve

1,367 

1,439 

181 

Share option reserve

1,169 

 480 

-

Retained profit

3,136 

1,073 

213 

Shareholders' Equity

83,168 

 

80,368 

 

69,120 

Minority Interests

2,821 

1,381 

11,612 

Total Equity

85,989 

 

81,749 

 

80,732 

Non-Current Liabilities

Long-term borrowings

11,098 

11,888 

10,615 

 

11,098 

 

11,888 

 

10,615 

Current Liabilities

Trade payables

1,789 

1,186 

777 

Other payables and accruals

4,866 

2,030 

1,470 

Short-term borrowings

47,930 

15,995 

12,136 

 

54,585 

 

19,211 

 

14,383 

Total Liabilities

65,683 

 

31,099 

 

24,998 

Total Equity and Liabilities

151,672 

 

112,848 

 

105,730 

Net assets per share (USD)

0.64

0.61 

0.53 

*Represents less than USD1.00.

¹ During the period the principal subsidiaries adopted US Dollar as their functional currency effective 1 July 2007. Under IAS21, the comparative audited financial information has been restated. No material adjustments resulted from the restatement. Full disclosure of the effects of the adjustments is set out in Note 2 of the Notes to the Interim Financial Statements.

  Condensed Consolidated Cash Flow Statement

For the Period Ended 31 December 2008

Restated¹

Restated¹

Unaudited

Audited

Audited

31 Dec 2008

30 Jun 2008

31 Dec 2007

USD '000

USD '000

USD '000

Cash Flows (for)/from Operating Activities

Profit before taxation

2,040 

1,130 

295 

Adjustments for:-

Amortisation of intangible assets

(32)

 33 

16 

Amortisation of prepaid land lease payments

18 

Depreciation of property, plant & equipment

1,097 

973 

459 

Equipment written off

40 

Interest expense

2,195 

1,039 

381 

Interest income

(277)

(600)

(127)

Unrealised gain on foreign exchange

(1,655)

Share of loss of an associate

25 

19 

Excess of Group's interest in the net fair value of acquiree's identifiable

assets, liabilities and and contingent liabilities over cost of acquisition

 (1,971)

Share option reserve

689 

480 

 

 

 

 

 

 

Operating cash flow before working capital changes

4,082 

1,103 

1,082 

(Increase)/Decrease in inventories

(26,239)

2,917 

(1,288)

Increase in trade and other receivables

(10,539)

(2,620)

(6,928)

Increase/(Decrease) in trade and other payables

3,445 

969 

(2,057)

 

 

 

 

 

 

Net cash (for)/ from operations

(29,251)

2,369 

(9,191)

Interest received

277 

600 

127 

Interest paid

(2,195)

(1,039)

(381)

Tax paid 

(13)

 

Net cash (for)/from operating activities

(31,182)

 

1,930 

 

(9,445)

Cash flows for investing activities

Acquisition of net assets in a subsidiary, net of cash acquired

(6,708)

Acquisition of intangible assets

(1,130)

(366)

(2,951)

Purchase of leasehold land

(26)

(828)

(851)

Purchase of property, plant & equipment

(17,611)

(5,027)

(2,658)

Net cash for investing activities

(18,767)

 

(6,221)

 

(13,168)

Cash flows from financing activities

Proceeds from issuance of shares

-

60,920 

Admission to AIM market expenses

-

(3,318)

Proceeds from disposal of treasury shares

120 

120 

84 

Net drawdown of term loans

33,183 

3,685 

3,348 

Proceeds of issuance of share to MI

-

-

5,830 

Net cash from financing activities

33,303 

 

3,805 

 

66,864 

Effect of foreign exchange rate changes on cash and cash equivalents

 (72)

805 

(507)

Net (Decrease)/Increase in cash and cash equivalents

(16,718)

319 

43,744 

Cash & cash equivalents at beginning of period

44,063 

43,744 

-

Cash & cash equivalents at end of period

27,345 

44,063 

 43,744 

¹ During the period the principal subsidiaries adopted US Dollar as their functional currency effective 1 July 2007. Under IAS21, the comparative audited financial information has been restated. No material adjustments resulted from the restatement. Full disclosure of the effects of the adjustments is set out in Note 2 of the Notes to the Interim Financial Statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BCGDXIUGGGCX

Related Shares:

PURE.L
FTSE 100 Latest
Value8,596.35
Change99.55